Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
ConclusionOur results demonstrate that the low prevalence of XDR-TB holds great promise for MDR-TB treatment with WHO-endorsed regimens containing BDQ-LZD combination, whereas the high prevalence of FQ-resistance in MDR-TB patients warrants national attention.
Source: Antimicrobial Resistance and Infection Control - Category: Infectious Diseases Source Type: research
More News: Antimicrobial Resistance | Avelox | Bedaquiline | China Health | Genetics | Infectious Diseases | Linezolid | Moxifloxacin | Multidrug Resistance | Study | Tuberculosis | Zyvox